# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-061495
Filing Date
2022-05-16
Accepted
2022-05-16 17:16:01
Documents
3
Period of Report
2022-06-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm223666-2_def14a.htm | DEF 14A | 847258
2 | GRAPHIC | tm223666d1-px_proxy1pg1bw.jpg | GRAPHIC | 915644
3 | GRAPHIC | tm223666d2-px_proxy1pg2bw.jpg | GRAPHIC | 500874
| Complete submission text file | 0001104659-22-061495.txt |  | 2797549

Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39683 | Film No.: 22930913
SIC: 2834 Pharmaceutical Preparations